ARSYNL Rx, a leader in provider-guided telehealth and modern hormone access, today announced the launch of its exclusive HypoSpray® transdermal testosterone option, the first spray-on testosterone ...
Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results